Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2022-11-09 00:00:00 ET · period of report 2022-11-07 · accession 0001209191-22-056318 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-09 | 2022-11-07 | FLGT | Hsieh Ming | CEO, Dir, 10% | A - Grant | $39.02 | +566.2K | 596.2K | +1,887% | +$22.09M | |
| I | 2022-11-09 | 2022-11-07 | FLGT | Hsieh Ming | CEO, Dir, 10% | A - Grant | $39.02 | +220.8K | 220.8K | New | +$8.62M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-07 | A | A | 566,171 | $39.02 | 596,171 | D By Trust | — | — | (F3) Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein. |
| 2 | Common | Common Stock | 2022-11-07 | A | A | 220,816 | $39.02 | 220,816 | I | — | — |